Patents Assigned to Ariceum Therapeutics GmbH
  • Patent number: 11969484
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: April 30, 2024
    Assignee: Ariceum Therapeutics GmbH
    Inventors: Marie Delporte, Sabine Hovest, Jens Kaufmann, Dennis Mewis, Anne Petit, Joel Richard